Cargando…

Correction to: CART cells are prone to Fas- and DR5-mediated cell death

Detalles Bibliográficos
Autores principales:	Tschumi, Benjamin O., Dumauthioz, Nina, Marti, Bastien, Zhang, Lianjun, Lanitis, Evripidis, Irving, Melita, Schneider, Pascal, Mach, Jean-Pierre, Coukos, George, Romero, Pedro, Donda, Alena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154881/ https://www.ncbi.nlm.nih.gov/pubmed/30253808 http://dx.doi.org/10.1186/s40425-018-0410-2

Ejemplares similares

CART cells are prone to Fas- and DR5-mediated cell death
por: Tschumi, Benjamin O., et al.
Publicado: (2018)

Targeting the tumor vasculature to enhance T cell activity
por: Lanitis, Evripidis, et al.
Publicado: (2015)

miR-155 Overexpression in OT-1 CD8(+) T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen
por: Monnot, Gwennaëlle C., et al.
Publicado: (2019)

Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity
por: Dumauthioz, Nina, et al.
Publicado: (2020)

Tumor targeting of innate and adaptive immunity by the adoptive cell transfer of engineered T lymphocytes co-expressing iNKT and tumor-specific MHC-I TCRs
por: Tschumi, Benjamin O, et al.
Publicado: (2014)

Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells
por: Irving, Melita, et al.
Publicado: (2021)

Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression
por: Lanitis, Evripidis, et al.
Publicado: (2020)

Inhibition of mTORC2/Akt signaling to enhance the therapeutic potential of CD8 T cells
por: Zhang, Lianjun, et al.
Publicado: (2015)

VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding
por: Lanitis, Evripidis, et al.
Publicado: (2021)

Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
por: Zhang, Lianjun, et al.
Publicado: (2017)

The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function
por: Wenes, Mathias, et al.
Publicado: (2022)

Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels
por: Lanitis, Evripidis, et al.
Publicado: (2012)

iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
por: Corgnac, Stéphanie, et al.
Publicado: (2014)

CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
por: Corgnac, Stéphanie, et al.
Publicado: (2012)

Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8(+) T cells
por: Corria-Osorio, Jesus, et al.
Publicado: (2023)

Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
por: Chiang, Cheryl L-L, et al.
Publicado: (2011)

In vivo CART cell imaging: Paving the way for success in CART cell therapy
por: Sakemura, Reona, et al.
Publicado: (2021)

Combination of Synthetic Long Peptides and XCL1 Fusion Proteins Results in Superior Tumor Control
por: Botelho, Natalia K., et al.
Publicado: (2019)

CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues
por: Cribioli, Elisabetta, et al.
Publicado: (2022)

Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
por: Irving, Melita, et al.
Publicado: (2017)

Mesenchymal stem cells enhance CCL8 expression by podocytes in lupus-prone MRL.Fas(lpr) mice
por: Kim, Hyung Sook, et al.
Publicado: (2023)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)

Effect of Human Mesenchymal Stem Cells on Xenogeneic T and B Cells Isolated from Lupus-Prone MRL.Fas(lpr) Mice
por: Lee, Hong Kyung, et al.
Publicado: (2020)

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity
por: Cox, Michelle J., et al.
Publicado: (2022)

Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival
por: Karapetsas, Athanasios, et al.
Publicado: (2015)

Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)
por: Cai, Guoqing, et al.
Publicado: (2015)

Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
por: Facciabene, Andrea, et al.
Publicado: (2017)

Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells
por: Lu, Jun, et al.
Publicado: (2018)

Expression of DR4, DR5, FAS, Caspase-8 and, DDIAS Genes in AML Patients
por: Naghinezhad, Jalal, et al.
Publicado: (2023)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
por: Atsuta, Ikiru, et al.
Publicado: (2013)

Involvement of the Fas and Fas ligand in testicular germ cell apoptosis by zearalenone in rat
por: Jee, Youngheun, et al.
Publicado: (2010)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
por: Gu, Tae Woo, et al.
Publicado: (2014)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995)

Impairment of Fas-ligand–caveolin-1 interaction inhibits Fas-ligand translocation to rafts and Fas-ligand-induced cell death
por: Glukhova, Xenia A., et al.
Publicado: (2018)

Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy
por: Dumauthioz, Nina, et al.
Publicado: (2018)

CART cell therapy for prostate cancer: status and promise
por: Yu, Haiyuan, et al.
Publicado: (2019)

CART Cell Toxicities: New Insight into Mechanisms and Management
por: Zahid, Anas, et al.
Publicado: (2020)

Cartes postales électroniques
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_ghvqa4cdiisvedlvfhiebmlmjh